Comparative study of Chinese hamster ovary cell versus escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model

Journal of Periodontology

Volumn 84, Issue 3, 2013, Pages 415-422

  Lee, Jaebum ^a   Lee, Eui Nam ^b   Yoon, James ^a   Chung, Sung Min ^c   Prasad, Hari ^d   Susin, Cristiano ^a   Wikesjö, Ulf M E ^a  

^a AUGUSTA UNIVERSITY   (United States)

^b Daewoong Co   (South Korea)

^c Dentium Co   (South Korea)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alveolar ridge augmentation; Bone morphogenetic protein 2; CHO cells; Dental implants; Escherichia coli; Growth differentiation factors

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALVEOLAR BONE LOSS; ANIMAL; ANIMAL MODEL; ARTICLE; BONE REGENERATION; CHEMISTRY; CHO CELL; COMPARATIVE STUDY; CRICETULUS; DOG; DRUG EFFECT; ESCHERICHIA COLI; EVALUATION; FEMALE; HAMSTER; JAW; MALE; ORAL SURGERY; SEROMA; SURGICAL MESH; TOOTH IMPLANT;

ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CHO CELLS; CRICETINAE; CRICETULUS; DENTAL IMPLANTS; DOGS; ESCHERICHIA COLI; FEMALE; MALE; MODELS, ANIMAL; ORAL SURGICAL PROCEDURES; OSSEOINTEGRATION; RECOMBINANT PROTEINS; SEROMA; SURGICAL MESH; TRANSFORMING GROWTH FACTOR BETA;

EID: 84874614050     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110369     Document Type: Article

References (47)

1. Urist MR. Bone: Formation by autoinduction. Science 1965;150: 893-899.
2. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 1988;85: 9484-9488. (Pubitemid 19027155)
3. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242: 1528-1534. (Pubitemid 19023695)
4. Ö zkaynak E, Rueger DC, Drier EA, et al. OP-1 cDNA encodes an osteogenic protein in the TGF-b family. EMBO J 1990;9: 2085-2093.
5. Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87: 9843-9847. (Pubitemid 120016540)
6. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87: 2220-2224.
7. Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267: 20352-20362.
8. Hötten G, Neidhardt H, Jacobowsky B, Pohl J. Cloning and expression of recombinant human growth/differentiation factor 5. Biochem Biophys Res Commun 1994;204: 646-652.
9. Hötten GC, Matsumoto T, Kimura M, et al. Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 1996;13: 65-74. (Pubitemid 26194047)
10. Li RH, Wozney JM. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 2001;19: 255-265. (Pubitemid 32537763)
11. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 1997;74: 659-670.
12. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 1997;79: 1778-1790. (Pubitemid 28016582)
13. Kirker-Head CA, Gerhart TN, Armstrong R, Schelling SH, Carmel LA. Healing bone using recombinant human bone morphogenetic protein 2 and copolymer. Clin Orthop Relat Res 1998;349: 205-217. (Pubitemid 28196566)
14. Welch RD, Jones AL, Bucholz RW, et al. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res 1998;13: 1483-1490. (Pubitemid 28418916)
15. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 1991;117: 1101-1112.
16. Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UM. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 1997;12: 604-610. (Pubitemid 127500122)
17. Hanisch O, Tatakis DN, Rohrer MD,Wöhrle PS, Wozney JM, Wikesjö UM. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 1997;12: 785-792. (Pubitemid 127500139)
18. Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjö UM. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997;8: 367-374. (Pubitemid 127688511)
19. Jovanovic SA, Hunt DR, Bernard GW, et al. Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003;14: 793-803. (Pubitemid 37524152)
20. Lee J, Susin C, Rodriguez NA, et al. Sinus augmentation using rhBMP-2/ACS in a mini-pig model: relative efficacy of autogenous fresh particulate iliac bone grafts [published ahead of print January 26, 2012]. Clin Oral Implants Res 2012; doi:10.1111/j.16000501. 2011.02419.x.
21. Federal Drug Administration. http://www.accessdata. fda.gov/cdrh-docs/ pdf/p000054a.pdf. Accessed.
22. Federal Drug Administration. http://www.accessdata. fda.gov/cdrh-docs/ pdf/P000058a.pdf. Accessed.
23. Israel DI, Nove J, Kerns KM, Moutsatsos IK, Kaufman RJ. Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. Growth Factors 1992;7: 139-150.
24. Ruppert R, Hoffmann E, Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 1996;237: 295-302. (Pubitemid 26110301)
25. Vallejo LF, Brokelmann M, Marten S, et al. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 2002;94: 185-194. (Pubitemid 34127660)
26. Kübler NR, Reuther JF, Faller G, Kirchner T, Ruppert R, Sebald W. Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. Int J Oral Maxillofac Surg 1998;27: 305-309. (Pubitemid 128364308)
27. Bessho K, Konishi Y, Kaihara S, Fujimura K, Okubo Y, Iizuka T. Bone induction by Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. Br J Oral Maxillofac Surg 2000;38: 645-649. (Pubitemid 32051101)
28. Huh JB, Park CK, Kim SE, et al. Alveolar ridge augmentation using anodized implants coated with Escherichia coli-derived recombinant human bone morphogenetic protein 2. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112: 42-49.
29. Harada Y, Itoi T, Wakitani S, et al. Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defects. J Bone Miner Metab 2012;30: 388-399.
30. Wikesjö UM, Qahash M, Thomson RC, et al. Spaceproviding expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res 2003;5: 112-123. (Pubitemid 37158043)
31. Wikesjö UM, Qahash M, Polimeni G, et al. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: Histologic observations. J Clin Periodontol 2008;35: 1001-1010.
32. Wikesjö UM, Susin C, Qahash M, et al. The critical-size supraalveolar peri-implant defect model: Characteristics and use. J Clin Periodontol 2006;33: 846-854. (Pubitemid 44511036)
33. Li XJ, Jee WS. Integrated bone tissue anatomy and physiology. In: Deng HW, Liu YZ, Guo CY, Chen D, eds. Current Topics in Bone Biology. Singapore: World Scientific Publishing Company; 2005: 11-56.
34. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique. J Oral Pathol 1982;11: 318-326. (Pubitemid 12092572)
35. Rohrer MD, Schubert CC. The cutting-grinding technique for histologic preparation of undecalcified bone and bone-anchored implants. Improvements in instrumentation and procedures. Oral Surg Oral Med Oral Pathol 1992;74: 73-78.
36. Barnhart HX, Haber MJ, Lin LI. An overview on assessing agreement with continuous measurements. J Biopharm Stat 2007;17: 529-569. (Pubitemid 47027007)
37. Lee JH, Kim CS, Choi KH, et al. The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. Biomaterials 2010;31: 3512-3519.
38. Choi Y, Yun JH, Kim CS, Choi SH, Chai JK, Jung UW. Sinus augmentation using absorbable collagen sponge loaded with Escherichia coli-expressed recombinant human bone morphogenetic protein 2 in a standardized rabbit sinus model: A radiographic and histologic analysis. Clin Oral Implants Res 2012;23: 682-689.
39. Tatakis DN, Koh A, Jin L, Wozney JM, Rohrer MD, Wikesjö UM. Peri-implant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model: A dose-response study. J Periodontal Res 2002;37: 93-100.
40. Lee J, Decker JF, Polimeni G, et al. Evaluation of implants coated with rhBMP-2 using two different coating strategies: A critical-size supraalveolar peri-implant defect study in dogs. J Clin Periodontol 2010;37: 582-590.
41. Decker JF, Lee J, Cortella CA, et al. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs. J Periodontol 2010;81: 1839-1849.
42. Wikesjö UM, Qahash M, Thomson RC, et al. rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 2004;15: 194-204. (Pubitemid 40109804)
43. Wikesjö UM, Sorensen RG, Kinoshita A, Wozney JM. rhBMP-2/alphaBSM induces significant vertical alveolar ridge augmentation and dental implant osseointegration. Clin Implant Dent Relat Res 2002;4: 174-182.
44. Russell WM, Burch RL. The Principles of Humane Experimental Technique. London:Methuen & Co.; 1959.
45. Wikesjö UM, Kean CJ, Zimmerman GJ. Periodontal repair in dogs: Supraalveolar defect models for evaluation of safety and efficacy of periodontal reconstructive therapy. J Periodontol 1994;65: 1151-1157.
46. Polimeni G, Wikesjö UM, Susin C, et al. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: Histologic observations. J Clin Periodontol 2010;37: 759-768.
47. Susin C, Qahash M, Polimeni G, et al. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP- 1): Histological observations. J Clin Periodontol 2010;37: 574-581.